Optiscan Imaging Limited OIL Financial and Strategic SWOT Analysis Review [Report Updated: 10102018] Prices from USD $125

00:53 EDT 25 Oct 2018 | BioPortfolio Reports

Optiscan Imaging Limited OIL Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Optiscan Imaging Limited Optiscan is a technology and product development company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company's key product is ViewnVivo, a miniaturized fluorescence endomicroscope platform that brings the new generation of Optiscan's incredible imaging capability and flexibility to preclinical research. Optiscan develops products based on Optiscan FIVE1 and Pentax ICS1000 platforms. The company conducts clinical trials on micro imaging in the fields of gastrointestinal endoscopy, neurosurgery, ENT and spinal surgery, endometriosis, bronchoscopy and robotic prostate surgery. It has distributors in Japan, Taiwan, China, South Korea and India. Optiscan is headquartered in Mulgrave, Victoria, Australia.

Optiscan Imaging Limited Key Recent Developments

Jun 13,2018: Optiscan Provides Market Update

Apr 16,2018: Optiscan Imaging: Successful European conference participation

Feb 28,2018: Optiscan MidYear Results JulyDecember 2017

Jan 22,2018: Optiscan Imaging Announces Resignation of Archie Fraser As CEO

Sep 14,2017: Optiscan Appoints Exclusive China Distributor

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Optiscan Imaging Limited OIL Financial and Strategic SWOT Analysis Review [Report Updated: 10102018] Prices from USD $125


More From BioPortfolio on "Optiscan Imaging Limited OIL Financial and Strategic SWOT Analysis Review [Report Updated: 10102018] Prices from USD $125"

Quick Search


Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...